We are live on ! Find out more
TCBPW

TC BioPharm (Holdings) plc Warrants

Delisted

TCBPW was delisted on the 21st of March, 2025.

6 hedge funds and large institutions have $108K invested in TC BioPharm (Holdings) plc Warrants in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 3 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less funds holding

Funds holding: 76 (-1)

92% less capital invested

Capital invested by funds: $1.36M → $108K (-$1.25M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
KC
1
Kepos Capital
New York
$66K
NCM
2
Nantahala Capital Management
Connecticut
$21K
WAM
3
Warberg Asset Management
Illinois
$10.9K
AC
4
Armistice Capital
New York
$5.27K -$253K -1,844,705 -98%
VF
5
Virtu Financial
New York
$3K -$638 -4,649 -18%
ACM
6
Altium Capital Management
New York
$1.68K -$127K -922,353 -98%

TCBPW Hedge Fund Activity: Q4 2022 in Review

6 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q4 2022, worth a combined $108K — down 92% from $1.36M a quarter earlier.

Fund positioning in TCBPW was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 3 trimmed.

The largest seller was Armistice Capital, cutting an estimated $253K.

  • 6 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q4 2022, down from 7 in Q3 2022.
  • Funds reported $108K of TC BioPharm (Holdings) plc Warrants stock for Q4 2022, down 92% quarter-over-quarter.
  • 0 funds opened new TC BioPharm (Holdings) plc Warrants positions in Q4 2022 and 0 closed out.
  • The largest TC BioPharm (Holdings) plc Warrants seller in Q4 2022 was Armistice Capital, an estimated $253K sold.

Based on aggregated 13F filings for Q4 2022.